Aura Biosciences (AURA) EV to FCF (2021 - 2026)
Powered by 
Analysis
Aura Biosciences (AURA) EV to FCF (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Aura Biosciences | 709.58 Mn | 641.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.17 |
| Mar 31, 2026 | -11.48 |
| Dec 31, 2025 | -13.90 |
| Sep 30, 2025 | -16.47 |
| Jun 30, 2025 | -13.42 |
| Mar 31, 2025 | -11.21 |
| Dec 31, 2024 | -15.64 |
| Sep 30, 2024 | -26.78 |
| Jun 30, 2024 | -20.75 |
| Mar 31, 2024 | -14.74 |
| Dec 31, 2023 | -17.51 |
| Sep 30, 2023 | -18.54 |
| Jun 30, 2023 | -28.66 |
| Mar 31, 2023 | -18.80 |
| Dec 31, 2022 | -10.49 |
| Sep 30, 2022 | -43.38 |
| Jun 30, 2022 | -33.72 |
| Mar 31, 2022 | -33.82 |
| Dec 31, 2021 | 4.76 |